Cost-Effectiveness of a Multicancer Early Detection Test in the US
Under a range of likely clinical scenarios, MCED testing was estimated to be cost-effective, improving survival and reducing treatment costs.
Authors
- Weicheng Ye (ORCID: https://orcid.org/0000-0001-7145-9335)
- Ameya Chavan (ORCID: https://orcid.org/0000-0001-5296-6550)
- Ali Tafazzoli (ORCID: https://orcid.org/0000-0003-1874-1467)
- Alissa Shaul (ORCID: https://orcid.org/0000-0002-5444-3785)
- A. Mark Fendrick (ORCID: https://orcid.org/0000-0002-7734-6742)
- Denise Zou (ORCID: https://orcid.org/0009-0002-5549-7475)
Institutions
- Grail (United States) (US)
Publication Details
- Journal
- The American Journal of Managed Care
- Published
- 2024-12-13
- DOI
- https://doi.org/10.37765/ajmc.2024.89643
- Citations
- 8
- Primary Topic
- Colorectal Cancer Screening and Detection
- Type
- article
- Field-Weighted Citation Impact
- 2.26